Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer

Gemcitabine has been used as first-line chemotherapy against lung cancer, but many patients experience cancer recurrence. Activation of anti-tumor immunity in vivo has become an important way to prevent recurrence. Anti-tumor immune responses are often dependent upon the immunogenicity of tumors. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Wang, Dong, Li, Zhidong, Jiao, Defeng, Jin, Linlin, Cong, Jingjing, Zheng, Xiaohu, Xu, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052388/
https://www.ncbi.nlm.nih.gov/pubmed/32161598
http://dx.doi.org/10.3389/fimmu.2020.00331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052388/
https://www.ncbi.nlm.nih.gov/pubmed/32161598
http://dx.doi.org/10.3389/fimmu.2020.00331

Ejemplares similares